|
1
|
Lu XJ, Shi Y, Chen JL and Ma S:
Kruppel-like factors in hepatocellular carcinoma. Tumour Biol.
36:533–541. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yu WB, Rao A, Vu V, Xu L, Rao JY and Wu
JX: Management of centrally located hepatocellular carcinoma:
Update 2016. World J Hepatol. 9:627–634. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hu J and Gao DZ: Distinction immune genes
of hepatitis-induced heptatocellular carcinoma. Bioinformatics.
28:3191–3194. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Marquardt JU, Galle PR and Teufel A:
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC):
An emerging field for advanced technologies. J Hepatol. 56:267–275.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol.
15(429)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Qadir MI and Faheem A: miRNA: A diagnostic
and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene
Expr. 27:197–204. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer.
17(147)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sartorius K, Sartorius B, Winkler C,
Chuturgoon A and Makarova J: The biological and diagnostic role of
miRNA's in hepatocellular carcinoma. Front Biosci (Landmark Ed).
23:1701–1720. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Mao B and Wang G: MicroRNAs involved with
hepatocellular carcinoma (Review). Oncol Rep. 34:2811–2820.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
He S, Zhang DC and Wei C: MicroRNAs as
biomarkers for hepatocellular carcinoma diagnosis and prognosis.
Clin Res Hepatol Gastroenterol. 39:426–434. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang J, Chong CC, Chen GG and Lai PB: A
Seven-microRNA expression signature predicts survival in
hepatocellular carcinoma. PLoS One. 10(e0128628)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qin L, Huang J, Wang G, Huang J, Wu X, Li
J, Yi W, Qin F and Huang D: Integrated analysis of clinical
significance and functional involvement of microRNAs in
hepatocellular carcinoma. J Cell Physiol. 234:23581–2395.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lu M, Kong X, Wang H, Huang G, Ye C and He
Z: A novel microRNAs expression signature for hepatocellular
carcinoma diagnosis and prognosis. Oncotarget. 8:8775–8784.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nagy A, Lanczky A, Menyhart O and Gyorffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep.
8(9227)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen W, Gao C, Liu Y, Wen Y, Hong X and
Huang Z: Bioinformatics analysis of prognostic miRNA signature and
potential critical genes in colon cancer. Front Genet.
11(478)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang H, Wang Z, Ma R, Wu J and Feng J:
MicroRNAs as biomarkers for the progression and prognosis of colon
carcinoma. Int J Mol Med. 42:2080–2088. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Villanueva A, Hoshida Y, Toffanin S,
Lachenmayer A, Alsinet C, Savic R, Cornella H and Llovet JM: New
strategies in hepatocellular carcinoma: Genomic prognostic markers.
Clin Cancer Res. 16:4688–4694. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jiang L, Cheng Q, Zhang BH and Zhang MZ:
Circulating microRNAs as biomarkers in hepatocellular carcinoma
screening: A validation set from China. Medicine (Baltimore).
94(e603)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Petrini E, Caviglia GP, Abate ML, Fagoonee
S, Smedile A and Pellicano R: MicroRNAs in HBV-related
hepatocellular carcinoma: Functions and potential clinical
applications. Panminerva Med. 57:201–209. 2015.PubMed/NCBI
|
|
23
|
Xie Y, Du J, Liu Z, Zhang D, Yao X and
Yang Y: miR-6875-3p promotes the proliferation, invasion and
metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. J
Exp Clin Cancer Res. 38(7)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
You Y, Que K, Zhou Y, Zhang Z, Zhao X,
Gong J and Liu Z: MicroRNA-766-3p inhibits tumour progression by
targeting Wnt3a in hepatocellular carcinoma. Mol Cells. 41:830–841.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Żorniak M, Garczorz W, Wosiewicz P, Marek
T, Błaszczyńska M, Waluga M, Kukla M, Kimsa-Furdzik M, Francuz T
and Hartleb M: Mucosal miR-3677 is over-expressed in cirrhotic
patients with gastric antral vascular ectasia (GAVE). Scand J
Gastroenterol. 53:1503–1508. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lu DC, Han W and Lu K: Identification of
key microRNAs involved in tumorigenesis and prognostic microRNAs in
breast cancer. Math Biosci Eng. 17:2923–2935. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Peng LN, Deng XY, Gan XX, Zhang JH, Ren
GH, Shen F, Feng JH, Cai WS and Xu B: Targeting of TLE3 by miR-3677
in human breast cancer promotes cell proliferation, migration and
invasion. Oncol Lett. 19:1409–1417. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yao B, Li Y, Niu Y, Wang L, Chen T, Guo C
and Liu Q: Hypoxia-induced miR-3677-3p promotes the proliferation,
migration and invasion of hepatocellular carcinoma cells by
suppressing SIRT5. J Cell Mol Med. 24:8718–8731. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li Y, Zhou Y, Ma L, Liu D, Dai Z and Shen
J: miR-3677-3p promotes hepatocellular carcinoma progression via
inhibiting GSK3β. Acta Biochim Biophys Sin (Shanghai).
52:1404–1412. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Robinson NB, Krieger K, Khan FM, Huffman
W, Chang M, Naik A, Yongle R, Hameed I, Krieger K, Girardi LN and
Gaudino M: The current state of animal models in research: A
review. Int J Surg. 72:9–13. 2019.PubMed/NCBI View Article : Google Scholar
|
